The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Primary results from the Phase II ARASEC trial show that NUBEQA® (darolutamide) plus androgen deprivation therapy (ADT) showed a statistically significant improvement in progression-free survival (PFS ...
Multi-center and pre-clinical studies demonstrate high stone clearance and aspiration efficiency of the CVAC System compared to suction sheaths and direct-in-scope suction (DISS) Large retrospective ...
OSLO, Norway, May 18, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the presentation of two Photocure-supported abstracts at the American Urological Association ...
Sumitomo Pharma America, Inc. (SMPA) today announced the presentation of new data from its urology and oncology portfolios at the American Urological Association (AUA) 2026 Annual Meeting, held on May ...
OSLO, Norway, May 18, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the presentation of two Photocure-supported abstracts at the American Urological Association ...
Calyxo, Inc., a medical device company redefining kidney stone treatment, today highlighted the results from multiple studies presented at the American Urological Association (AUA) 2026 Annual Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results